CAPR Capricor Therapeutics Inc.


210,350 Shares Traded
744,700 Average Volume (last 30 days)

as of February 23, 2018 EST IEX Real-Time Price

Short Pain Metrics

Approximate Amount of Money Shorts Have Made on the Day: $2.58 million
If Intiated on the First, Shorts Have Realized a Year to Date Return of:-15.29%
If Intiated One Month Ago, Shorts Have Realized a Return of:-9.04%
If Initiated Five Days ago, Shorts Have Realized a Return of:9.5%
Peer Potential Short Squeezes Near Real Time Screener
*Please note the actual returns of shorts could be different as they started from different points

Daily Indicators

Daily Short Pain Indicator [i] - Always Use Fundamentals on EverythingNeutral
200 Day Moving Average Indicator Bearish
50 Day Moving Average Indicator Bearish
52 Week High/Low Indicator Neutral

Short Stats

Short Percent to Float 7.05%
Short Interest1.46 million
Float20.72 million
Short Ratio2.62
Market Cap$46.54 million
Market Maker ActivityDaily Short Volume


Catabasis Pharma's edasalonexent shows positive effect in mid-stage DMD study; shares up 62% (SeekingAlpha)
Biolife Solutions: A Diversified, Profitable Play On Gene Therapy And Regenerative Medicine (SeekingAlpha)
3 Things In Biotech You Should Learn Today: February 7, 2018 (SeekingAlpha)
Premarket Losers as of 9:05 am (2/6/2018) (SeekingAlpha)
Your Daily Pharma Scoop: AMAG Gets Label Expansion For Feraheme, Bristol-Myers Squibb Reports Results, EyeGate Shares Tumble (SeekingAlpha)
Premarket Gainers as of 9:05 am (02/05/2018) (SeekingAlpha)
Capricor nabs accelerated review status in U.S. for Duchenne candidate CAP-1002; shares up 9% premarket (SeekingAlpha)
Solid Biosciences slips (SeekingAlpha)
Midday Gainers / Losers (1/26/2018) (SeekingAlpha)
Capricor breaks out of consolidation, up 30% (SeekingAlpha)

Smart Money Sentiment

Institutional Ownership (Top 15 Funds) 18.9%

Earnings Stats

PE Ratio -3.07
Dividend Yield 0%
Peer EarningsEarnings Calendar


200 Day Moving Average $1.58
50 Day Moving Average $1.72
52 Week High $4.25
52 Week Low $0.63

Data provided for free by IEX. Questions? Read the FAQ